Prezma et al. have synthesized VDAC1-based peptides and considered them as Antp-LP4 and N-terminal-Antp that could specifically destroy peripheral blood mononuclear cells pulled from patients with chronic lymphocytic leukemia. This evidence concerns the gene HOXA7 and B-cell chronic lymphocytic leukemia.